Dr Zolman's Work
Longevity School
Dr Zolman created a new medical specialty (LEVMED) with its own peer-reviewed AGREE2/IPDAS compliant clinical practice guidelines around the Level 123 protocol, to test if it outperforms standard care and achieves LEV. Pseudoscience free. longevity.school
Level 1, 2, 3 Longevity Protocol
Created the Level 1, 2, 3 protocol to integrate all current & future aging tests and therapies e a single personalised adaptive health protocol to prove N=1 rejuvenation in all organs.
The 81 Organ Framework & Zolman Clocks
Dr Zolman created the concept of measuring aging in all 81 organ types, using Zolman Clocks, with biostatistical rigour (publications pending) to prove rejuvenation & N=1 LEV.
Competitive Rejuvenation
Dr Zolman created the field of evidence-based competitive rejuvenation, through the Zolman Rejuvenation Leaderboards on his website and rejuvenationolympics.com
Project Blueprint
Dr Zolman uses his Longevity Level 123 protocol on his client Bryan Johnson, Bryan has documented his journey through this as 'Project Blueprint' protocol.bryanjohnson.com
Tripl Helix
Dr Zolman leads the biomarkers science at the world's most advanced consumer longevity gene therapy program. triplhelix.com
Skin Stories Clinic
Dr Zolman co-founded SkinStories in 2024, a holistic skin health service providing personalised treatments based on biomarkers testing, digital hub consultations with various specialists and onsite clinic visits. At SkinStories, he combines his innovative approach to aging and wellness with a commitment to helping clients achieve optimal skin health and overall vitality. skinstories.clinic
Charity & Venture Fund
Funding therapies stuck in research that can rejuvenate highly important organs: with randomised controlled trials (RCTs) that meet CONSORT criteria.
GeekFood
Where science meets seasoning: geek.food
Specialist Consultancy in Experimental Evidence-Based Rejuvenation.
20one Consulting aim to be the first to prove N=1 Longevity Escape Velocity, through rigorously peer-reviewed studies, including showing evidence individuals are 25% younger in all 81 organ types & multi-organ clocks by 2030.
The Longevity Level 1, 2, 3 framework was made to integrate all evidence-based longevity tests & therapies, including pre-commercial ones, into a single, adaptive, personalised experimental protocol
The protocol provides the maximum theoretical chance of reaching age 100+ in good health compared to any other health protocol globally
Longevity Level 1
Completing Level 1 gives you a 95% chance of living to age 75, with high health expectancy
Longevity Level 2
Completing Level 2 gives the averge person increased quality of life up to age 75, but has insufficient evidence for increasing life expectancy beyond this age in people already doing Level 1
Longevity Level 3
Level 3 therapies are required to have certainty of being healthy past age 75
Level 3 includes tests and therapies
Tests: Measure biological age accurately in each of the 81 organ types in individuals, as well as multi-organ biological age tests. Biostatistical accuracy is according to peer-reviewed Zolman Biological Age Marker Criteria (Z-BAM) (currently under NDA) with a strict biostatistical testing methodology.
Therapies: Use of all existing clinical practice guidelines for ageing conditions across all medical specialties is included in Level 3, e.g. statins, blood pressure medication, or cardiac or cancer surgery, with the additional use of further Level 3 Therapy Experimental Clinical Practice Guidelines for therapies that lack sufficiently good guidelines, all of which are AGREE-II and IPDAS compliant. Level 3 therpaies are organ or multi-organ targeted and attempt experimental reversal of the biological age of each organ in individuals.
